ISRG Maintained by BTIG -- Price Target Lowered to $454

gurufocus.com · 2026-10-12

Intuitive Surgical (ISRG) Analyst Rating Update On October 12, 2026, BTIG analyst Ryan Zimmerman maintained a 'Buy' rating for Intuitive Surgical (ISRG) but

TickrTrends take: BTIG's decision to maintain its rating while lowering the price target to 454 dollars suggests the analyst sees sustainable fundamentals in the robotics-assisted surgery space despite near-term headwinds. This action comes as TickrTrends' analysis currently indicates ISRG is undervalued, which could represent a divergence worth monitoring between BTIG's cautious near-term positioning and the broader valuation metrics signaling upside potential. Investors focused on valuation should observe whether the 454 dollar target reflects temporary operational challenges or a more structural reassessment of the healthcare technology company's growth prospects.

Read the full story at gurufocus.com →